Structural and functional aspects of G protein-coupled receptor oligomerization.
暂无分享,去创建一个
[1] L. Potter,et al. Evidence of paired M2 muscarinic receptors. , 1991, Molecular pharmacology.
[2] M. Caron,et al. Phosphorylation and Palmitoylation of the Human D2L Dopamine Receptor in Sf9 Cells , 1994, Journal of neurochemistry.
[3] J. Lyons,et al. Functional Wild‐Type and Carboxy‐Terminal‐Tagged Rat Substance P Receptors Expressed in Baculovirus‐Infected Insect Sf9 Cells , 1995, Journal of neurochemistry.
[4] J. Wess,et al. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. W. Wells,et al. Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity. , 1997, Biochemistry.
[6] M. Kirschner,et al. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in xenopus embryos , 1991, Cell.
[7] S. Yen. Gonadotropin-releasing hormone. , 1975, Annual review of medicine.
[8] P. Phillips,et al. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. , 1989, The Journal of biological chemistry.
[9] J. W. Wells,et al. G protein-linked receptors labeled by [3H]histamine in guinea pig cerebral cortex. I. Pharmacological characterization [corrected]. , 1993, Molecular pharmacology.
[10] D. Engelman,et al. Sequence specificity in the dimerization of transmembrane alpha-helices. , 1992, Biochemistry.
[11] J. Khire,et al. Ligand-induced dimerization of the platelet-derived growth factor receptor. Monomer-dimer interconversion occurs independent of receptor phosphorylation. , 1989, The Journal of biological chemistry.
[12] M. Entman,et al. Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting. , 1985, The Journal of biological chemistry.
[13] D. Lancet,et al. Overexpression, solubilization and purification of rat and human olfactory receptors. , 1996, European journal of biochemistry.
[14] James H. Prestegard,et al. A Transmembrane Helix Dimer: Structure and Implications , 1997, Science.
[15] D. Engelman,et al. Glycophorin A dimerization is driven by specific interactions between transmembrane alpha-helices. , 1992, The Journal of biological chemistry.
[16] M. Caron,et al. Solubilization and Characterization of D2‐Dopamine Receptors in an Estrone‐Induced, Prolactin‐Secreting Rat Pituitary Adenoma , 1986, Journal of neurochemistry.
[17] E. Podesta,et al. Receptor aggregation induced by antilutropin receptor antibody and biological response in rat testis Leydig cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Bouvier,et al. Functional rescue of a constitutively desensitized beta2AR through receptor dimerization. , 1998, The Biochemical journal.
[19] R. Sunahara,et al. The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography. , 1992, European journal of pharmacology.
[20] M. Bitensky,et al. Cooperative binding of the retinal rod G-protein, transducin, to light-activated rhodopsin. , 1993, The Journal of biological chemistry.
[21] M. Caron,et al. Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. , 1989, The Journal of biological chemistry.
[22] J. W. Wells,et al. Cardiac muscarinic receptors. Relationship between the G protein and multiple states of affinity. , 1997, Biochemistry.
[23] D. Engelman,et al. A dimerization motif for transmembrane α–helices , 1994, Nature Structural Biology.
[24] E. Hulme,et al. Characterization of the rat m3 muscarinic acetylcholine receptor produced in insect cells infected with recombinant baculovirus. , 1995, European journal of biochemistry.
[25] Robert J. Lefkowitz,et al. β-Adrenergic receptors: Evidence for negative cooperativity , 1975 .
[26] J. W. Wells,et al. Cooperativity Manifest in the Binding Properties of Purified Cardiac Muscarinic Receptors (*) , 1995, The Journal of Biological Chemistry.
[27] L. Devi,et al. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.
[28] J. Benovic,et al. Agonist-dependent phosphorylation of human muscarinic receptors in Spodoptera frugiperda insect cell membranes by G protein-coupled receptor kinases. , 1995, Molecular pharmacology.
[29] D E Koshland,et al. Aspartate receptors of Escherichia coli and Salmonella typhimurium bind ligand with negative and half-of-the-sites cooperativity. , 1994, Biochemistry.
[30] J. Venter,et al. Radiation inactivation (target size analysis) of the gonadotropin-releasing hormone receptor: evidence for a high molecular weight complex. , 1985, Endocrinology.
[31] M. Ultsch,et al. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.
[32] H. Fukui,et al. Determination of the molecular size of the hepatic H1-receptor by target size analysis. , 1986, Biochemical and biophysical research communications.
[33] G. McFadden,et al. The complete DNA sequence of myxoma virus. , 1999, Virology.
[34] D. Koshland,et al. Intrasubunit signal transduction by the aspartate chemoreceptor. , 1991, Science.
[35] M. Caron,et al. Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. , 1994, European journal of pharmacology.
[36] W. Moolenaar,et al. C-terminal Truncation of the Neurokinin-2 Receptor Causes Enhanced and Sustained Agonist-induced Signaling , 1995, The Journal of Biological Chemistry.
[37] Y. Yarden,et al. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. , 1987, Biochemistry.
[38] J. Venter,et al. Alpha 1-adrenergic receptor structure. , 1984, Molecular pharmacology.
[39] P. Strange. Dopamine D4 receptors: curiouser and curiouser. , 1994, Trends in pharmacological sciences.
[40] J. Stock,et al. Bacterial chemotaxis and the molecular logic of intracellular signal transduction networks. , 1991, Annual review of biophysics and biophysical chemistry.
[41] J. Wess,et al. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co‐expressed receptor polypeptide. , 1996, The EMBO journal.
[42] C. Hopkins,et al. Luteinizing hormone release from dissociated pituitary cells by dimerization of occupied LHRH receptors , 1982, Nature.
[43] Pierre Corvol,et al. Polar Residues in the Transmembrane Domains of the Type 1 Angiotensin II Receptor Are Required for Binding and Coupling , 1996, The Journal of Biological Chemistry.
[44] S Avissar,et al. Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[45] M. Caron,et al. Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. , 1993, Biochemistry.
[46] B. Mouillac,et al. Palmitoylated Cysteine 341 Modulates Phosphorylation of the β2-Adrenergic Receptor by the cAMP-dependent Protein Kinase* , 1996, The Journal of Biological Chemistry.
[47] E. J. Fletcher,et al. A Comparison of Two Alternatively Spliced Forms of a Metabotropic Glutamate Receptor Coupled to Phosphoinositide Turnover , 1993, Journal of neurochemistry.
[48] B. Kobilka,et al. Co-expression of Defective Luteinizing Hormone Receptor Fragments Partially Reconstitutes Ligand-induced Signal Generation* , 1997, The Journal of Biological Chemistry.
[49] B. Bormann,et al. Synthetic peptides mimic the assembly of transmembrane glycoproteins. , 1989, The Journal of biological chemistry.
[50] E. Hazum,et al. Gonadotropin releasing hormone activation is mediated by dimerization of occupied receptors. , 1985, Biochemical and biophysical research communications.
[51] E. Podesta,et al. Luteinizing hormone triggers two opposite regulatory pathways through an initial common event, receptor aggregation. , 1986, Endocrinology.
[52] R. Weis,et al. Oligomerization of the cytoplasmic fragment from the aspartate receptor of Escherichia coli. , 1992, Biochemistry.
[53] J. Venter,et al. Molecular size of the canine and human brain D2 dopamine receptor as determined by radiation inactivation. , 1983, Molecular pharmacology.
[54] R. Snyderman,et al. Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. Role of multiple G proteins and receptor phosphorylation. , 1994, The Journal of biological chemistry.
[55] J. Stewart,et al. Conversion of a gonadotropin-releasing hormone antagonist to an agonist , 1982, Nature.
[56] Y. Yarden,et al. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. , 1987, Biochemistry.
[57] C. Heldin,et al. Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. , 1989, The Journal of biological chemistry.
[58] J. Venter,et al. Molecular size of the human platelet alpha 2-adrenergic receptor as determined by radiation inactivation. , 1983, Biochemical and biophysical research communications.
[59] G. Johnson,et al. Allosteric behavior in transducin activation mediated by rhodopsin. Initial rate analysis of guanine nucleotide exchange. , 1987, The Journal of biological chemistry.
[60] B. Mouillac,et al. Altered phosphorylation and desensitization patterns of a human beta 2‐adrenergic receptor lacking the palmitoylated Cys341. , 1993, The EMBO journal.
[61] G. Corsini,et al. Functional Role of the Third Cytoplasmic Loop in Muscarinic Receptor Dimerization* , 1996, The Journal of Biological Chemistry.
[62] G. Peterson,et al. Physical properties of the purified cardiac muscarinic acetylcholine receptor. , 1986, Biochemistry.
[63] Christer Halldin,et al. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone , 1995, Psychiatry Research: Neuroimaging.
[64] W. Schlegel,et al. Structure of the turkey erythrocyte adenylate cyclase system. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[65] C. Reynolds,et al. Simulations on dimeric peptides: evidence for domain swapping in G-protein-coupled receptors? , 1997, Biochemical Society transactions.
[66] M. Schimerlik,et al. A kinetic model for oxotremorine M binding to recombinant porcine m2 muscarinic receptors expressed in Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.
[67] J. W. Wells,et al. G protein-linked receptors labeled by [3H]histamine in guinea pig cerebral cortex. II. Mechanistic basis for multiple states of affinity [corrected]. , 1993, Molecular pharmacology.
[68] A. Hinko,et al. Molecular size characterization of oxytocin receptors in rabbit amnion. , 1992, Endocrinology.
[69] J. Wess,et al. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication. , 1997, The Journal of clinical investigation.
[70] J. Venter,et al. The size of the mammalian lung beta 2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography. , 1982, Biochemical and biophysical research communications.
[71] J. Venter,et al. Target size of the adenosine Ri receptor. , 1986, The Biochemical journal.
[72] R. Iyengar,et al. The hepatic glucagon receptor. Solubilization, characterization, and development of an affinity adsorption assay for the soluble receptor. , 1984, The Journal of biological chemistry.
[73] B. Goldstein,et al. Dynamics of signal transduction after aggregation of cell-surface receptors: studies on the type I receptor for IgE. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[74] S. Nagpal,et al. Ligand-induced receptor dimerization may be critical for signal transduction by choriogonadotropin. , 1997, Biophysical journal.
[75] Michel Bouvier,et al. A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.
[76] A. Ullrich,et al. Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond. , 1994, The Journal of biological chemistry.
[77] D. Goeddel,et al. Interferon-gamma induces receptor dimerization in solution and on cells. , 1993, The Journal of biological chemistry.
[78] L. Brouchon,et al. Identification of the Major Phosphorylation Sites in Human C5a Anaphylatoxin Receptor in Vivo(*) , 1995, The Journal of Biological Chemistry.
[79] J. Venter. Muscarinic cholinergic receptor structure. Receptor size, membrane orientation, and absence of major phylogenetic structural diversity. , 1983, The Journal of biological chemistry.
[80] R. Neubig,et al. Multisite interactions of receptors and G proteins: enhanced potency of dimeric receptor peptides in modifying G protein function. , 1994, Molecular Pharmacology.
[81] P. Seeman,et al. Dopamine receptor pharmacology. , 1994, Trends in pharmacological sciences.
[82] P. Seeman,et al. Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.
[83] C. Romano,et al. Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer* , 1996, The Journal of Biological Chemistry.
[84] Thomas Gudermann,et al. Structural basis of G protein-coupled receptor function , 1999, Molecular and Cellular Endocrinology.